# The Study of a Selective Serotonin Partial Agonist and Reuptake Inhibitors, HEC113995PA•H2O,in Healthy Subjects

> **NCT03943251** · PHASE1 · COMPLETED · sponsor: **Sunshine Lake Pharma Co., Ltd.** · enrollment: 69 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** HEC113995PA•H2O tablet
- **DRUG:** Placebo tablet

## Key facts

- **NCT ID:** NCT03943251
- **Lead sponsor:** Sunshine Lake Pharma Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-07-04
- **Primary completion:** 2019-12-11
- **Final completion:** 2019-12-11
- **Target enrollment:** 69 (ACTUAL)
- **Last updated:** 2021-05-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03943251

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03943251, "The Study of a Selective Serotonin Partial Agonist and Reuptake Inhibitors, HEC113995PA•H2O,in Healthy Subjects". Retrieved via AI Analytics 2026-07-30 from https://api.ai-analytics.org/clinical/NCT03943251. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*